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Abstract A peptidomics approach was developed to identify
transglutaminase-susceptible Q residues within a pepsin^trypsin
gliadin digest. Based on tagging with a monodansylcadaverine
£uorescent probe, six K/L-, Q-gliadin, and low molecular weight
glutenin peptides were identi¢ed by nanospray tandem mass
spectrometry. In functioning as an acyl acceptor, tissue trans-
glutaminase was able to form complexes with the glutamine-rich
gliadin peptides, whereas by lowering pH, the peptides were
deamidated by transglutaminase at the same Q residues, which
were previously transamidated. The main common feature
shared by the peptides was the consensus sequence Q-X-P.
Our ¢ndings o¡er relevant information for the understanding
of how dietary peptides interact with the host organism in celiac
disease.
) 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Celiac disease (CD) is an enteropathy of the small intestine
induced by dietary exposure to gluten proteins and other pro-
lamins [1]. As a result of gluten ingestion CD patients develop
the anti-gliadin antibody and anti-tissue transglutaminase
(tTG) autoantibodies [2]. tTG is a calcium-dependent enzyme
capable of deamidating peptide-bound glutamine (Q) residues
to glutamic acid (E) and cross-linking Q residues with O-amino
groups of peptide-bound Lys (K) [2,3]. The Q-X-P consensus
sequence (X represents any amino acid residue) is mostly pre-
ferred by tTG [3].
Gluten proteins and derived peptides are also good sub-
strates for tTG-catalyzed cross-linking given the high fre-
quency of Q residues, which account for about 40% [4,5]. In
addition to forming gliadin^gliadin complexes, tTG can be
incorporated into high molecular weight complexes with glia-
dins [6], giving rise to novel antigenic epitopes [2]. Further-
more, it has been demonstrated that tTG can selectively de-
amidate gluten peptide, which results in strongly enhanced
T cell-stimulatory activity [6^9].
In a slightly acidic environment, as in chronic in£amma-
tion, tTG-induced gliadin peptide cross-linking (transamida-
tion) decreases, whereas deamidation increases [3]. Both post-
translational modi¢cations, transamidation and deamidation,
play a key role in the pathogenesis of CD by generating a
variety of haptens which, in addition to others, are responsible
for an autoimmune response [2,3,6^9].
The majority of these studies have been carried out mainly
on recombinant gliadin and synthetic peptides [6^9]. Gluten
has been so infrequently used in such studies because the
complexity of the chemistry of the cereal proteins has made
it extremely di⁄cult to ¢nd their toxic components. Previous
studies have demonstrated that gliadin and glutenin are each
composed of at least 50 closely related species [10].
Peptidomics has become an e⁄cient tool for the rapid iden-
ti¢cation of peptides in complex mixtures, and could therefore
facilitate identi¢cation of tTG-mediated modi¢cations of pep-
tides. In the present study, we developed a peptidomics-based
procedure to individuate selectively, amongst the complex
gliadin fraction of a wheat variety, the main gliadin peptides
that are susceptible to tTG.
2. Materials and methods
2.1. Materials
When not speci¢ed, reagents were from C. Erba (Milan, Italy).
Guinea pig tTG, monodansylcadaverine (MDC), pepsin (porcine
stomach mucosa), goat anti-rabbit IgG alkaline phosphatase, and
trypsin TPCK were from Sigma Chemical Co. (St. Louis, MO,
USA). Guinea pig tTG (Sigma) was puri¢ed according to Leblanc
et al. [11]. Wheat £our was obtained from a 25 kg grain lot of Italian
winter variety (cv. Strampelli). Synthetic peptides and polyclonal anti-
body were from PRIMM (Milan, Italy).
2.2. Peptic^tryptic (PT) gliadin digestion and treatment with tTG
One milligram of gliadin puri¢ed according to Wieser et al. [12] was
dissolved in 1 ml of 5% formic acid and incubated in a 37‡C water
bath with pepsin (1:100 enzyme:substrate ratio) for 2 h. Before tryp-
sin digestion, the sample was evaporated and washed twice with de-
ionized water. Trypsin was added at an enzyme/substrate ratio of
1:100 in 1 ml of 100 mM ammonium bicarbonate (pH 8) and the
mixture was incubated for 4 h at 37‡C. The reaction was stopped by
heating for 5 min and the sample was evaporated and washed twice
with deionized water. 1 mg of PT was incubated with tTG (1:50
enzyme:substrate ratio) at 37‡C for 0, 2, or 4 h in 5 mM Tris^HCl
bu¡er, pH 7.6, containing 2 mM MDC, 5 mM CaCl2, 10 mM NaCl,
and 10 mM dithiothreitol (¢nal volume 1 ml). PT and synthetic pep-
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tide deamidation were carried out with tTG (1:1 enzyme:substrate
ratio) in the bu¡er used for transamidation without MDC brought
to pH 6.8. The tTG-catalyzed reaction was stopped by adding 8 Wl
0.4 M EDTA.
2.3. High performance liquid chromatography (HPLC) and liquid
chromatography/electrospray mass spectrometry (LC/MS)
Liquid chromatography was performed using a 2.1 mm i.d.U250
mm, C18, 5 Wm (Vydac, Hesperia, CA, USA) reverse-phase column
with a £ow rate of 0.2 ml/min on a HP1100 modular system (Hewlett-
Packard, Palo Alto, CA, USA). Solvent A was 0.1% tri£uoroacetic
acid (TFA) (v/v) in water; solvent B was 0.1% TFA in acetonitrile.
The column was equilibrated at 5% solvent. Separation of the peptides
was e¡ected with a gradient of 5^70% solvent B over 90 min. The
column e¥uent was monitored both by UV detector (absorbance at
220 nm) and by £uorimetric detector (Vexc 338 nm, Vem 500 nm).
The e¥uent from the detector was injected on-line into a Platform
(Micromass, UK) mass spectrometer equipped with a standard elec-
trospray source via a 75 Wm i.d. fused silica capillary. The mass
spectra were scanned from 2000 to 400 atomic mass units at a scan
cycle of 5 s/scan. The source temperature was held at 180‡C and the
cone voltage at 40 V. Mass scale calibration was obtained using
myoglobin as reference compound.
2.4. Identi¢cation of MDC-tagged and deamidated peptide by nano-ES
tandem mass spectrometry (nES-MS/MS)
Each HPLC £uorescent top peak was manually collected and ana-
lyzed by nES-MS/MS to identify peptides. A Q-STAR mass spectrom-
eter (PE Sciex, Toronto, ON, Canada) equipped with a nanospray
interface (Protana, Odense, Denmark) was used. The capillary voltage
used was 800 V. Doubly and triply charged precursor ion isotopic
clusters were selected by the quadrupole mass ¢lter (MS1) and then
induced to fragment by collision with collision energy varied between
20 and 40 V, depending on the mass and charge state of the peptides.
The deconvoluted MS/MS spectra were manually interpreted with the
aid of the Analyst software (PE Sciex).
The determined amino sequence was used as input to search the
corresponding peptides in the NCBI database. The search was carried
out using the PROTEIN PROSPECTOR/MS-PATTERN software
(http://prospector.ucsf.edu).
2.5. Immunoblotting
One hundred microgram of both 19-mer synthetic peptide
(LGQQQPFPPQQPYPQPQPF) and puri¢ed guinea pig tTG dis-
solved in a 1 ml pH 7.6 bu¡er was incubated for 4 h and at 37‡C.
The reaction was stopped by freeze-drying and the sample analyzed
on standard 12.5% Tris-glycine sodium dodecyl sulfate (SDS) gel elec-
trophoresis. 20 Wg incubated protein was applied per lane and proteins
were transferred to a nitrocellulose membrane sheet by a routine semi-
dry blotting technique. Subsequently, the membrane was incubated
overnight at 4‡C in a pH 7.5 TBS bu¡er containing 10% horse serum
as blocking solution followed by a 60 min incubation with anti-syn-
thetic peptide antibody preparation, 1:1000 (v/v) diluted. After three
washes with 10% horse serum the membrane was further incubated
with an anti-rabbit goat IgG-alkaline phosphatase conjugate contain-
ing 0.1% Tween 20 (Bio-Rad, Hercules, CA, USA). To visualize ad-
ducts, an incubation with Western blue-stabilized substrate for alka-
line phosphatase (Immuno-Star; Bio-Rad) was carried out.
3. Results
In order to detect gliadin peptides derived from gastric and
pancreatic digestion possibly modi¢ed by tTG, we developed
an analytical approach capable of selective probing of suscep-
tible Q sites within these peptides. The whole gliadin fraction,
isolated from a winter wheat £our variety according to the
procedure described by Wieser et al. [12], was therefore di-
gested with pepsin and trypsin. LC/MS of the PT digest
showed the presence of an extraordinary number of peaks
(Fig. 1A). Running the molecular mass value through data
bank archives did not give us identi¢cation of the formed
peptides. To compensate, we developed a basic strategy using
MDC as chemical label to identify the tTG-susceptible pep-
tides in the complex PT digest. Fluorescent MDC enabled us
to be selective in the labelling of Q residues in the presence of
tTG by incubating the PT gliadin digest under conditions
described in Section 2. The HPLC pro¢le indicated the for-
mation of six and 10 £uorescent peaks, after 2 and 4 h in-
cubation time, respectively (Fig. 1B,C). Each HPLC peak top
was characterized by nES-MS/MS. Peak 1 gave the spectrum
in Fig. 2 corresponding to a Q-MDC-tagged peptide. The
mass spectrum obtained by selecting the appropriate posi-
tively charged precursor (Fig. 2) displayed a complete ‘b-’
and ‘y-ion’ series. The localization within the peptide chain
of the Q residue susceptible to tTG was evident in the char-
acteristic fragmentation by the 446.22 Da loss corresponding
to Q-MDC instead of 128.05 Da of the native Q residue. In
this way, e¡ective individuation of tTG-susceptible peptides
was facilitated, while the interference from non-speci¢c re-
agent binding peptides was minimized. In Table 1, the overall
MDC-tagged peptides identi¢ed in the PT digest by tTG ac-
tion are shown. The 14- (peak 1), 21- (peak 2), 14- (peak 3),
19- (peak 4), 18- (peak 5) and 25-mer (peak 6) peptides bound
each MDC residue at sites Q9, Q12, Q10, Q4, Q9 and Q16 in the
respective chains, while other Q endoresidues were una¡ected.
After 4 h incubation, tTG further modi¢ed Q residues of
peptides 1, 3, 4, and 6, giving rise to the respective two-MDC
derivatives (Table 1).
With this amino acid sequence information, we searched for
a counterpart in data bank archives. All the identi¢ed se-
quence peptides di¡ered from those reported in the archives
by at least one amino acid substitution or deletion. The only
exception was peptide 19-mer (K/L-gliadin 31^49), which was
found unaltered (peaks 4 and 9, Table 1). Sequence informa-
tion on peptides reported in Table 1 made ¢ngerprinting pos-
sible for K/L-, Q-gliadin, and low molecular weight glutenin as
Fig. 1. HPLC analysis of the PT digest of the gliadin fraction iso-
lated from a common wheat variety. Detection of peptides by (A)
LC/MS, (B,C) £uorescence after PT 2 h and 4 h incubation, with
tTG, MDC and calcium ions, in a pH 7.6 bu¡er. Numbered peaks
were manually collected and each directly analyzed by nES-MS/MS
analysis.
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parent protein. This means that the K/L-, and Q-gliadin and a
glutenin fraction could be substrates for in vivo transamida-
tion by tTG.
In addition, because gliadin proteins are rich in Q and poor
in K residues [4,5], in the absence of MDC, tTG may act as an
acyl acceptor and form complexes with gliadin peptides. As-
says to detect gliadin peptide^tTG complexes were unsuccess-
ful owing to the high heterogeneity of the reaction mixture
and the very high molecular weight of the protein^peptide
complexes. This heterogeneity would be resolved if, instead
of a whole gliadin PT digest (mimicking in vivo digestion),
single synthetic peptides amongst those identi¢ed were incu-
bated with tTG. To this end, we developed polyclonal anti-
bodies against the 19-mer peptide K/L-gliadin 31^49 (peaks 4
and 9, Table 1), known to be toxic for CD patients [13], as a
putative substrate in forming peptide^tTG complexes. The
choice of this peptide was determined also based on its high
Q residue content; that is, a total of seven, with two belonging
to the tTG-preferred consensus sequence Q-X-P [3]. SDS^
polyacrylamide gel electrophoresis (PAGE) analysis carried
out on the reaction mixture containing the gliadin peptide
and tTG in the presence of calcium at pH 7.6 allowed us to
detect a band ofV80 kDa recognized by the antibodies raised
against the synthetic peptide (Fig. 3, lane 3). There was no
reactivity in the corresponding tTG positive control (lane 2)
with reference to tTG migration (lane 1). Notably, this clearly
indicated that the 19-mer peptide formed relatively stable and
covalent aggregates with tTG in the absence of other binding
molecules.
As previously shown [3], the capacity of tTG to mediate
gliadin peptides and protein cross-linking could be abolished
by lowering the pH of the reaction to values around 6.8 in the
absence of amines. In these conditions, water may act as an
acyl acceptor substrate with subsequent deamidation of pro-
tein-bound glutamine residues [3]. To test this prediction in
vitro, the PT gliadin digest was incubated with tTG at pH 6.8.
An HPLC pro¢le similar to that in Fig. 1A was obtained (not
shown), showing unresolved the individual peptide species
that di¡ered by either one molecular mass unit or multiple
values. Therefore, to evaluate the propensity of the peptides
Fig. 2. nES-MS/MS analysis of the peptide isolated by HPLC (Fig. 1, peak 1) from the PT digest of gliadin incubated with tTG and MDC at
pH 7.6. Q-(MDC) indicates a Q residue cross-linked with MDC.
Fig. 3. SDS^PAGE separation of the 4 h incubated mixture of the
synthetic 19-mer peptide (see peaks 4 and 9 in Table 1) incubated
with a large tTG excess. Lane 1, reference tTG, staining with Coo-
massie blue. Lanes 2 and 3, staining with anti-19-mer antibodies
against synthetic peptide; lane 2, reference tTG and lane 3, mixture
of tTG and synthetic peptide incubated for 4 h. Control tTG
showed no anti-peptide antibody binding.
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to deamidation, synthetic counterparts mimicking the natural
gliadin components identi¢ed in Table 1 were used as tTG
substrates. An example of the propensity of gliadin peptides
to be deamidated is shown in Fig. 4, where the nES-MS/MS
spectrum of 14-mer peptide (peaks 1 and 7, Table 1) evi-
denced the formation of E2 and E9 (Fig. 4B) from the native
Q2 and Q9 (Fig. 4A). Similarly, all the other peptides shown
in Table 1 were deamidated at the Q sites previously binding
MDC, once they were incubated in conditions favoring de-
amidation by tTG.
4. Discussion
Identi¢cation of gliadin Q residues susceptible to cross-link-
ing or to deamidation by tTG is a challenging task. Overlap-
ping of peptides with similar size and hydrophobicity from
Table 1
Identi¢cation by nES-MS/MS of MDC-tagged Q residue gliadin peptides isolated from the £uorescent PT digest by HPLC fractionation (Fig.
1B,C)
Q* indicates transamidated Q residues. Amino acid residues are indicated with a single letter nomenclature. Boxed residues indicate substituted
or deleted amino acid residues along the peptide chain found under the indicated accession number in the NCBI Data Bank archive (lower
line).
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HPLC fractionation represents one of the main problems
while identi¢cation is further complicated by the analysis of
a highly complex protein digest. After probing the complex
mixture of the PT gliadin digest with MDC, and fractionation
by HPLC, the transamidated components became £uorescent
since they contain a selected consensus sequence targeted by
tTG. They were sequenced in spite of the overlapping non-
derivative peptides, which then did not interfere in the mass
spectrum of the £uorescent peptide.
For the ¢rst time in a wheat £our, this procedure allowed
us to identify, as tTG substrates in vitro, a few gliadin pep-
tides having a speci¢c amino acid composition amongst a
myriad of other peptides. Contrary to what was expected,
only a few gliadin peptides interacted with tTG even if a
high content of Q residues was available along the gliadin
chains [4,5]. Only one belonged to the Q-X-Q consensus se-
quence (peak 7, Table 1) while Q residues occupying the
32 position with respect to a P residue were preferentially
modi¢ed, con¢rming previous data concerning tTG speci¢city
[3].
Amongst the identi¢ed peptides, an 18 and a 25 residue
long peptide (Table 1) were both internal to a 33-mer putative
precursor, previously isolated from the recombinant K-gliadin
digest [14] and already indicated as a possible trigger for the
in£ammatory response to gluten in CD patients [14]. This 33-
mer peptide did not occur in the PT digest of gliadin £our.
However, the 18-mer peptide (peak 5, Table 1) corresponded
to a fragment of the 25-mer peptide (peaks 6 and 10) with
seven truncated N-terminal residues. Compared to the peptide
from recombinant gliadin [14], the natural sequence gliadin
had substitution L7 for P7 (peaks 6 and 10, Table 1), meaning
that the amino acid sequence of natural gliadin was sensitive
to pepsin at the L7-Q8 bond, while the P7-Q8 peptide bond of
recombinant gliadin was not. An additional peptide bond
Fig. 4. nES-MS/MS analysis of the synthetic 14-mer peptide in the native (A) and deamidated form after tTG treatment (B). Peptide sequence
is indicated at the top of the spectrum. The sequence of the tTG-deamidated peptide indicated native Q2 and Q9 were converted into E2 and
E9.
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sensitive to pepsin (or trypsin) was missing in recombinant
gliadin since no homologous counterpart to the 25-mer pep-
tide (peak 6, Table 1) was found in the PT digest. Therefore,
drawing general conclusions from studies carried out on re-
combinant proteins should be avoided because the genetic
evolution of cereals could generate new peptides with null
or attenuated toxicity in CD patients.
The presence of MDC derivatives indicated that the native
gliadin peptides are tTG substrates. In the absence of acyl
acceptors and pH higher than 7, the immunoblotting experi-
ment (Fig. 3) showed that gliadin peptides were perfectly ca-
pable of forming complexes with tTG, just like other struc-
tural proteins having a K site available. The conjugate
constituted by one or more units of dietary peptides cross-
linked to tTG, producing a net increase of antigen size, would
be able to generate autoantibodies against tTG in CD pa-
tients. This reaction merely consists of a conjugation of exog-
enous peptide(s) to tTG as a carrier protein. In this case, a
population of antibodies is produced by the living organism
recognizing both the prolamin antigen and tTG itself, as this
latter was modi¢ed by cross-linked gliadin peptides through
an O-(Q-glutamyl)-lysine (isopeptidyl) bond.
It can be generally concluded that in CD pathogenesis at
pH above 7.0, it is possible that peptides with a high Q residue
content are prevalently transamidated by tTG giving in-
creased levels of serum antibodies speci¢c for gluten, trans-
glutaminase, and other antigens simultaneously. Hence, as the
pH decreased from pH 7 [3], residual tTG-sensitive Q residue
peptides crossing the lamina propria are deamidated and then
become able to bind the HLA-DQ2/DQ8 molecule on anti-
gen-presenting cells [6,9]. The identi¢ed gliadin peptides (Ta-
ble 1), all found deamidatable by tTG, are good candidates
for recognition by intestinal T cells from CD patients.
In conclusion, the outlined procedure could be used to
probe peptides susceptible to tTG in any food, even in a
duodenal mucosal biopsy, and to obtain their structural char-
acterization. A positive response with the £uorescent probe
would predict the presence of a speci¢c tTG-susceptible Q
residue determinant potentially toxic to a genetically predis-
posed subject. Therefore, a systematic screening of foods with
this type of predictive test could help assure safer food for CD
patients.
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